12156844 · Active · incorporated 7 years, 2 months ago · London
Biotech Biotech & Life Sciences Drug Discovery Healthcare Series B+
Alchemab Therapeutics is a biopharmaceutical company that develops therapeutic antibodies by harnessing the immune system.
Alchemab Therapeutics Ltd is a private limited company registered at Companies House under number 12156844, incorporated on 14 August 2019, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 92 filings for this company, including 6 funding rounds. Its most recent round closed in June 2026, raising £25m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 6 | Jun 2026 | £25m | £1.42 |
| Round 5 | Oct 2025 | £25.1m | £1.46 |
| Round 4 | Feb 2023 | £20m | £1.29 |
| Round 3 | Feb 2022 | £20m | £1.29 |
| Round 2 | Apr 2021 | £6m | £0.50 |
| Round 1 | Apr 2021 | £14m | £1.29 |
Showing the 12 most recent of 92 filings.
See the complete cap table with every shareholder, founder tags, dilution across 34 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.